Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H1VY
|
|||
| Former ID |
DNC012839
|
|||
| Drug Name |
2,4,6-Trihydroxy-3-nitro-N-tridecyl-benzamide
|
|||
| Synonyms |
CHEMBL175532; 2,4,6-Trihydroxy-3-nitro-N-tridecyl-benzamide; Benzamide, 2,4,6-trihydroxy-3-nitro-N-tridecyl-; 126395-25-3; ACMC-20mryy; RD34082; AC1LA66U; SCHEMBL12902000; CTK0F6648; DTXSID50333097; BDBM50158817; AKOS030576830; RD-3-4082
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H32N2O6
|
|||
| Canonical SMILES |
CCCCCCCCCCCCCNC(=O)C1=C(C(=C(C=C1O)O)[N+](=O)[O-])O
|
|||
| InChI |
1S/C20H32N2O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-21-20(26)17-15(23)14-16(24)18(19(17)25)22(27)28/h14,23-25H,2-13H2,1H3,(H,21,26)
|
|||
| InChIKey |
MSWMANFKQVMQAR-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 126395-25-3
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Hepatitis C virus NS3 helicase (HCV NS3) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Control of hepatitis C: a medicinal chemistry perspective. J Med Chem. 2005 Jan 13;48(1):1-20. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.